Qiu et al. (2023) shift the focus to liver enzyme markers, such as ALT, and their gender-specific associations with NAFLD [20] and identify distinct patterns in how these markers correlate with NAFLD risk in men and women. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.